In vitro bacteriostatic and bactericidal activity of meropenem against multiresistant Pseudomonas aeruginosa.

被引:0
|
作者
Delisle, F
Lesage, D
Barakett, V
Richard, G
Petit, JC
机构
来源
PATHOLOGIE BIOLOGIE | 1996年 / 44卷 / 05期
关键词
meropenem; P-aeruginosa; bacteriostatic activity; killing curves;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Meropenem is a new dehydropeptidase stable carbapenem which has an in vitro bacteriostatic activity superior to imipenem against Pseudomonas aeruginosa. Minimal inhibitory concentrations of meropenem (MEM) and imipenem (IPM) were determined on twelve strains : two were genetically characterized reference strains and ten isolated from patients. Killing curves were performed for MEM used at 1,2 and 4 fold the MIC and 32 mg/l; survivors were counted at baseline and after 5 and 24 hours of incubation by spiral plating. Five strains were susceptible to MEM and IPM; five were intermediate and two resistant to MEM; these seven strains were resistant to IPM. A weak bactericidal effect was obtained after 5 h at each concentration. Only one strain achieved a 3 log(10) reduction after 5 h at 2 x MIC. A regrowth of all the strains tested was observed after 24 h.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [1] COMPARATIVE IN-VITRO KILLING ACTIVITY OF MEROPENEM VERSUS IMIPENEM AGAINST MULTIRESISTANT NOSOCOMIAL PSEUDOMONAS-AERUGINOSA
    GIAMARELLOSBOURBOULIS, EJ
    GRECKA, P
    GIAMARELLOU, H
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (03) : 179 - 183
  • [2] In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa
    GarciaRodriguez, JA
    Blazquez, AM
    Fresnadillo, MJ
    Sanchez, EG
    Sanchez, JEG
    Martin, IT
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (05) : 358 - 364
  • [3] In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains
    Drulis-Kawa, Zuzanna
    Gubernator, Jerzy
    Dorotkiewicz-Jach, Agata
    Doroszkiewicz, Wlodzimierz
    Kozubek, Arkadiusz
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 315 (1-2) : 59 - 66
  • [4] In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii
    Guelfi, K. C.
    Tognim, M. C. B.
    Cardoso, C. L.
    Gales, A. C.
    Carrara-Marrone, F. E.
    Garcia, L. B.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 180 - 185
  • [5] Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program
    Turner, Philip J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (03) : 341 - 344
  • [6] In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains
    Erdem, I
    Kucukercan, M
    Ceran, N
    CHEMOTHERAPY, 2003, 49 (06) : 294 - 297
  • [7] Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa
    Kuti, JL
    Florea, NR
    Nightingale, CH
    Nicolau, DP
    PHARMACOTHERAPY, 2004, 24 (01): : 8 - 15
  • [8] The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains
    Erdem, I
    Kaynar-Tascioglu, J
    Kaya, B
    Goktas, P
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (05) : 384 - 386
  • [9] In vitro activity of cefiderocolcefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitorcombinationsinhibitor combinations
    Santerre Henriksen, Anne
    Jeannot, Katy
    Oliver, Antonio
    Perry, John D.
    Pletz, Mathias W.
    Stefani, Stefania
    Morrissey, Ian
    Longshaw, Christopher
    MICROBIOLOGY SPECTRUM, 2024, 12 (04):
  • [10] Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004
    Unal, S
    Garcia-Rodriguez, JA
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (04) : 265 - 271